MedTrace Logo

Evaluation of a Community Health Program for the Prevention of Type 2 Diabetes and Other Cardio-metabolic Risk Factors in Adults: Districts of Barranquilla and Bogota, Colombia - January 2017 - December 2019

NCT03049839 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 650

Last updated 2019-03-12

No results posted yet for this study

Summary

The main aim of this study is to evaluate the feasibility and effectiveness of a program for modifying lifestyles for diabetes prevention type 2 and control cardio-metabolic risk factors in adults with different categories of risk from the primary health care strategy.

The project will show the effect of these interventions for the first time in people With different risk of developing type 2 diabetes throughout the life in populations living in Colombia Located in 2 different cities, one of them in the interior of the country (districts of Bogota) and another in the north coast (districts of Barranquilla) .

Conditions

  • Prediabetic State

Interventions

BEHAVIORAL

Intervention_ S

One year Structured intervention program for members of high-risk group (Subjects with FINDRISC score ≥12 points and impaired glucose tolerance (IGT))

BEHAVIORAL

Intervention_ I

One year Informative intervention program for members of moderate risk group (People with normotolerant or impaired fasting glucose in the OGTT and a FINDRISC score ≥12 points)

BEHAVIORAL

Intervention_ C

One year, Intervention program at Community level. People with a FINDRISC less than 12 points

Sponsors & Collaborators

  • Universidad del Norte

    lead OTHER

Principal Investigators

  • Tania Acosta, MD, MPH · Universidad del Norte

  • Pablo Achner, MD, ENDOCRINOLOGIST · ASOCIACIÓN COLOMBIANA DE DIABETES

Study Design

Allocation
NON_RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
30 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2017-08-01
Primary Completion
2019-10-30
Completion
2019-12-30

Countries

  • Colombia

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03049839 on ClinicalTrials.gov